Skip to main content
. Author manuscript; available in PMC: 2019 Jan 5.
Published in final edited form as: Lab Invest. 2018 Jul 5;98(11):1449–1464. doi: 10.1038/s41374-018-0093-9

Table 1.

Evaluation of liver and body weight, and liver to body weight ratio, serum chemistry and levels of TGF-β1 in serum and cholangiocyte supernatant.

Parameters C57 FVB C57/FVB SR−/− Mdr2−/− SR−/−/Mdr2−/−

Liver weight (gm) 1.7±0.3 1.6±0.1 1.6±0.1 1.6±0.4 2.6±0.1* 2.2±0.1
n=34 n=13 n=12 n=15 n=15 n=11

Body weight (gm) 26.0±0.5 30.0±0.5 31.1±1.4 32.0 ± 1.5 30.6±0.4 30.6±1.1
n=34 n=13 n=12 n=15 n=15 n=11

Liver to body weight ratio (%) 6.4±0.2 5.4±0.1 5.2±0.3 5.7±0.2 8.5±0.3* 7.2±0.1#
n=34 n=13 n=12 n=15 n=15 n=11

SGPT (Units/L) 326.3±32.6 131.3±16.6 124.3±11.9 321.5±68.4 1153.5±55.6* 794.5±21.9#
n=4 n=4 n=4 n=4 n=4 n=4

SGOT (Units/L) 485.0±53.5 431.3±25.9 570±89.8 427.5±174.3 1710.3±216.8* 893.8±102.8#
n=4 n=4 n=4 n=4 n=4 n=4

ALP (Units/L) <45±5.0 <50±0.0 <56.5±6.5 <47.25±2.8 342.5±27.2* 237.0±17.5#
n=4 n=4 n=4 n=4 n=4 n=4

TGF-β1 levels in serum (pg/ml) 276.9±36.3 78.7±4.7 118.5±10.2 69.4±0.8 7970.7±304.8* 1617.5±132.3#
n=4 n=4 n=4 n=4 n=4 n=4

TGF-β1 levels in cholangiocyte supernatant (ng/ml) 4.0±0.5 0.5±0.3 1.3±0.5 24.7±1.2 764.5±30.0* 216.9±10.6#
n=4 n=4 n=4 n=4 n=4 n=4
*

P<0.05 vs. FVB mice;

#

P<0.05 vs. Mdr2−/− mice.